Erich Wedam, MD
Cardiovascular Disease · Bethesda, MDNPI 1821010943
Payments from drug & device makers
Across 33 payments — averaging $103.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Medtronic$596
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$88
- Boston Scientific$28
- Cook Medical LLC$16
- Biotronik Inc.$11
What the payments were for
- Travel & lodging$2,11762%
- Food & beverage$1,28538%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 23 | $2,663 |
| Medtronic(2 entities) | 6 | $596 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $88 |
| Boston Scientific | 1 | $28 |
| Cook Medical LLC | 1 | $16 |
| Biotronik Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AVEIR$1,767
- Micra$379
- Quadra Assura CRT Defibrillator$144
- GALLANT$119
How this compares
$3,402 in reported general payments places this provider in the 60th percentile of 507 cardiovascular disease providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 404 | $559,159 |
| XareltoRivaroxaban | 126 | $169,906 |
| EntrestoSacubitril/Valsartan | 80 | $117,356 |
| JardianceEmpagliflozin | 32 | $45,531 |
| MultaqDronedarone Hcl | 18 | $35,209 |
| Dofetilide | 15 | $5,362 |
| Atorvastatin Calcium | 261 | $4,873 |
| Metoprolol Succinate | 277 | $4,804 |
| Rosuvastatin Calcium | 228 | $3,909 |
| PradaxaDabigatran Etexilate Mesylate | 12 | $3,341 |
| Amiodarone Hcl | 63 | $2,174 |
| Flecainide Acetate | 46 | $1,901 |
| Ranolazine ErRanolazine | 19 | $1,750 |
| Losartan Potassium | 139 | $1,532 |
| Valsartan | 16 | $1,479 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Bethesda
- Mark HaigneyBethesda$121K
- Andrew AraiBethesda$43K
- Christopher DefilippiBaltimore$9.2M
- Thorsten LeuckerBaltimore$7.1M
- Joao LimaBaltimore$5.6M
- Jeffrey ColeBaltimore$4.8M
- Carlos InceBaltimore$3M
- Paul GurbelBaltimore$2.6M
- Navin KapurBaltimore$1.8M
- Vineet VenugopalLanham$1.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.